Printer-friendly version
All World Stem Cell Summit attendees receive a free copy of the World Stem Cell Report.
GPI produced the 2012 World Stem Cell Report in collaboration with the peer-reviewed journal Regenerative Medicine. International and interdisciplinary in scope, the Report illuminates key issues affecting translational research. Articles cover science, commercialization, policy, law, ethics, advocacy and country profiles. The Report is distributed to all World Stem Cell Summit attendees and is available online.
The annual World Stem Cell Report is published as a supplement to Regenerative Medicine. Through a special arrangement with our publication partners, we are able to provide free access to the 2012 World Stem Cell Report.
2012 World Stem Cell Report Table of Contents
|
Research & Development
|
Sponsors & Advertisements
|
- StemCells, Inc.: clinical trials of stem cell therapies for CNS disorders
M McGlynn
- Bioengineered vascular graft with autologous stem cells: first use in the clinic
M Olausson
- Key developments in stem cell therapy in cardiology
IH Schulman & JM Hare
- Stem cells and neurodegenerative diseases: where is it all going?
RA Barker
- Ophthalmologic stem cell transplantation therapies
TA Blenkinsop, B Corneo, S Temple & JH Stern
- From cellular therapies to tissue reprograming and regenerative strategies in the treatment of diabetes
C Ricordi, L Inverardi & J Domínguez-Bendala
- Convergence of gene and cell therapy
A Bersenev & BL Levine
Industry, Commercialization & Collaboration
- Industry highlights
D Ilic
- Researchers and the translational reality
K Aboody
- The Regenerative Medicine Coalition
F-R Lauter
- Collaborations in Stem Cell Science
J Thomas
- The International Translational Regenerative Medicine Center
M de Veuve Alexis, K-H Grinnemo & R Jove
Policy, Regulatory & Ethics
- Regulation, manufacturing and building industry consensus
R Deans
- Alliances, collaborations and consortia: the International Stem Cell Forum and its role in shaping global governance and policy
R Isasi
- Cell standardization: purity and potency
BJ Wagner
- Autologous cell therapies: challenges in US FDA regulation
TN McAllister, D Audley & N L'Heureux
- Autologous cell therapies: the importance of regulatory oversight
M Werner, T Mayleben & G Van Bokkelen
- Pay-to-participate funding schemes in human cell and tissue clinical studies
Douglas Sipp
Advocacy & Education
- The making of an advocate
A Fernandez
- The New York Stem Cell Foundation
S Solomon
- Why the stem cell sector must engage with social media
L Buckler
Around the World
- USA
KRW Matthews & ML Rowland
- Canada
L Willemse, U Ogbogu, S Johnson & M Rudnicki
- UK
E Culme-Seymour
- Sweden
O Hovatta
- Brazil
R Mendez-Otero & AC Campos de Carvalho
|
Contact Alan Fernandez to learn more: alan@genpol.org or call (650) 847-1640.
|
View innovative science, new technologies, industry updates and regulatory solutions. The top five posters will be published and recieve a cash prize. 
